Roche and Pernod get going early with dual tranche bonds

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Corporate Bonds

Roche and Pernod get going early with dual tranche bonds

Mike Turner
April 29, 2024 05:47 pm
Roche Madopar capsules for treatment of parkinsons disease. Image shot 2008. Exact date unknown.

Evidence grows that companies can sell bonds successfully any day of the week

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Corporate BondsHigh grade and crossover bondsFranceHealth and BiotechSwitzerlandEuroEurope
MT
Mike Turner
Corporate Debt Editor
Contact
Gift this article